Mount Lucas Management’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-6,096
Closed -$2.59M 164
2021
Q3
$2.59M Sell
6,096
-476
-7% -$201K 0.78% 51
2021
Q2
$2.36M Buy
6,572
+898
+16% +$297K 0.63% 54
2021
Q1
$1.6M Buy
5,674
+537
+10% +$154K 0.47% 53
2020
Q4
$1.46M Buy
+5,137
New +$1.44M 0.31% 96
2017
Q2
Sell
-2,614
Closed -$213K 161
2017
Q1
$213K Sell
2,614
-343
-12% -$28.7K 0.04% 110
2016
Q4
$251K Sell
2,957
-43
-1% -$3.38K 0.05% 107
2016
Q3
$224K Sell
3,000
-79
-3% -$6.27K 0.04% 117
2016
Q2
$234K Buy
+3,079
New +$224K 0.04% 97
2014
Q1
Sell
-6,591
Closed -$323K 112
2013
Q4
$323K Sell
6,591
-7,587
-54% -$355K 0.07% 74
2013
Q3
$583K Buy
14,178
+968
+7% +$36.9K 0.13% 72
2013
Q2
$464K Buy
+13,210
New +$435K 0.11% 64

Other funds holding WST

Mount Lucas Management's WST Position: Q4 2021 in Review

Mount Lucas Management sold out of West Pharmaceutical (WST) in Q4 2021, closing a stake of 6,096 shares — an estimated $2.59M sold.

Mount Lucas Management first reported a position in WST in Q2 2013 and held it in 11 quarters. The position peaked at $2.59M in Q3 2021. 729 funds tracked by Wall St. Rank hold WST as of Q4 2021.

  • Mount Lucas Management reported no remaining West Pharmaceutical position as of Q4 2021 after selling out during the quarter.
  • Mount Lucas Management sold 6,096 West Pharmaceutical shares in Q4 2021, an estimated $2.59M.
  • Mount Lucas Management first reported a position in West Pharmaceutical in Q2 2013 and held it in 11 quarters.
  • Mount Lucas Management's West Pharmaceutical position peaked at $2.59M in Q3 2021.
  • 729 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2021.

Based on Mount Lucas Management's 13F filing for Q4 2021, filed 14 Feb 2022.